Composites of poly(methyl methacrylate) with hybrid fillers (micro/nanohydroxyapatite): Mechanical, setting properties, bioactivity and cytotoxicity in vitro
Source abstract
Abstract
Novel composites of poly(methyl methacrylate) with silanized micro and nanohydroxyapatite (HA) particles were prepared. Coralina® HA was the MicroHA filler and synthetic NanoHA was the reinforcement. The influence of the total inorganic content and the proportion of micro‐ to NanoHA on the setting properties (i.e., setting time and peak polymerization temperature), compressive strength, and in vitro bioactivity in simulated body fluid (SBF) was analyzed. The novel composites exhibited appropriate handling properties. Compressive strength ranged between 71.30 ± 0.04 and 80.0 ± 2.4 MPa. The peak polymerization temperatures varied from 44.5 ± 0.5 to 50.8 ± 1.8°C, and thus complying with the ISO 5833 standard. The composites exhibited excellent calcium phosphate deposition in SBF and those with 30 wt% inorganic content showed no cytotoxicity on L929 fibroblastic cells. These results encourage further testing of these novel composites for potential future use in human health applications. POLYM. COMPOS., 34:1927–1937, 2013. © 2013 Society of Plastics Engineers
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Orthopaedic implants and arthroplasty
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Group of Biomaterials Division of Chemistry National Center for Scientific Research Havana Cuba
Department of Macromolecular Center of Biomaterials University of Havana Havana 10400 Cuba
Centre de Biomaterials i Enginyeria Tissular Universitat Politécnica de Valéncia 46022, Camí de Vera 14 Valéncia Spain
Funding
MAEC-AECID
References (50)
Show source-provided references
1. 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C ↗
2. 10.1002/app.2278710.1002/app.22787 ↗
3. 10.1016/j.matlet.2006.07.06810.1016/j.matlet.2006.07.068 ↗
4. 10.1016/S0142-9612(98)00062-310.1016/S0142-9612(98)00062-3 ↗
5. 10.1023/A:101367013200110.1023/A:1013670132001 ↗
6. 10.1023/A:100890721833010.1023/A:1008907218330 ↗
7. 10.1002/jbm.82027021810.1002/jbm.820270218 ↗
8. 10.1002/jbm.82025020210.1002/jbm.820250202 ↗
9. 10.1002/jbm.b.1048610.1002/jbm.b.10486 ↗
10. 10.1016/j.biomaterials.2004.10.04210.1016/j.biomaterials.2004.10.042 ↗
11. 10.4028/www.scientific.net/KEM.254-256.17310.4028/www.scientific.net/KEM.254-256.173 ↗
12. 10.4028/www.scientific.net/KEM.330-332.81510.4028/www.scientific.net/KEM.330-332.815 ↗
13. 10.1016/S0142-9612(00)00097-110.1016/S0142-9612(00)00097-1 ↗
14. 10.1002/(SICI)1097-4636(1999)48:2<150::AID-JBM9>3.0.CO;2-D10.1002/(SICI)1097-4636(1999)48:2<150::AID-JBM9>3.0.CO;2-D ↗
15. 10.1002/jbm.b.3016610.1002/jbm.b.30166 ↗
16. 10.1002/(SICI)1097-4636(199723)38:3<221::AID-JBM6>3.0.CO;2-R10.1002/(SICI)1097-4636(199723)38:3<221::AID-JBM6>3.0.CO;2-R ↗
17. 10.1016/S0142-9418(03)00073-410.1016/S0142-9418(03)00073-4 ↗
18. 10.1002/(SICI)1097-4636(19991205)47:3<353::AID-JBM9>3.0.CO;2-P10.1002/(SICI)1097-4636(19991205)47:3<353::AID-JBM9>3.0.CO;2-P ↗
19. Giunti A. · J. Orthop. Traumatol. · 1983 · 9 · 369
20. 10.1016/0142-9612(85)90039-010.1016/0142-9612(85)90039-0 ↗
21. Mongiorgi R. · Boll. Soc. Ital. Biol. Sper. · 1993 · 69 · 365
22. 10.1016/j.biomaterials.2003.10.01610.1016/j.biomaterials.2003.10.016 ↗
23. 10.1007/s12034-009-0069-x10.1007/s12034-009-0069-x ↗
24. 10.1163/15685620175311308810.1163/156856201753113088 ↗
25. 10.1016/j.actbio.2012.05.00710.1016/j.actbio.2012.05.007 ↗
26. 10.4236/eng.2011.3809610.4236/eng.2011.38096 ↗
27. Yaghmaie A. · J. Nanostruct. Chem. · 2011 · 2 · 29
28. 10.1039/a700573c10.1039/a700573c ↗
29. 10.1023/B:JMSM.0000021112.51065.4010.1023/B:JMSM.0000021112.51065.40 ↗
30. Serbetci K. · Turkish J. Med. Sci. · 2000 · 30 · 543
31. 10.1080/0091403030490310.1080/00914030304903 ↗
32. Kwon S.Y. · Biomed. Mater. Eng. · 1997 · 7 · 129
33. 10.1002/1097-4636(20010915)56:4<593::AID-JBM1132>3.0.CO;2-T10.1002/1097-4636(20010915)56:4<593::AID-JBM1132>3.0.CO;2-T ↗
34. 10.1016/0142-9612(95)98906-U10.1016/0142-9612(95)98906-U ↗
35. International Organization for Standardization · Biological Evaluation of Medical Devices Part 5: Test for In Vitro Cytotoxicity · 2009
36. López M. · Latin Am. Appl.Res. · 2008 · 38 · 227
37. 10.1590/S0100-4042201200090000410.1590/S0100-40422012000900004 ↗
38. International Organization for Standardization · Implants for Surgery—Acrylic Resin Cements · 2002
39. 10.1016/j.actbio.2005.11.00110.1016/j.actbio.2005.11.001 ↗
40. 10.1016/S0142-9612(01)00139-910.1016/S0142-9612(01)00139-9 ↗
41. Lewis G. · Biomed. Eng. Soc. Bull. · 1996 · 20 · 19
42. 10.1016/j.biomaterials.2006.07.04210.1016/j.biomaterials.2006.07.042 ↗
43. Morejón L. · Revista CENIC Ciencias Químicas · 2006 · 37 · 155
44. 10.1016/S0142-9612(01)00315-510.1016/S0142-9612(01)00315-5 ↗
45. 10.1016/S0142-9612(00)00233-710.1016/S0142-9612(00)00233-7 ↗
46. International Organization for Standardization · Biological Evaluation of Medical Devices—Part I: Evaluating and Testing · 2003
47. 10.1161/CIRCRESAHA.108.18130510.1161/CIRCRESAHA.108.181305 ↗
48. 10.1016/j.biomaterials.2009.02.04410.1016/j.biomaterials.2009.02.044 ↗
49. 10.1002/jbm.a.3221310.1002/jbm.a.32213 ↗
50. Shahoon H. · Ind. J. Med. Spec. · 2012 · 3 · 149